These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8671110)

  • 21. [Organ protection in hypertensive type 2 diabetic patients. Double chance with AT1 blockers].
    MMW Fortschr Med; 2000 Jan; 142(3):58-9. PubMed ID: 10726465
    [No Abstract]   [Full Text] [Related]  

  • 22. Angiotensin receptor antagonists as a treatment for hypertension.
    MacFadyen RJ; Reid JL
    J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690
    [No Abstract]   [Full Text] [Related]  

  • 23. [Losartan (LORZAAR) and Losartan/hydrochlorothiazide (LORZAAR-PLUS)--their value in hypertension therapy. Symposium on the occasion of the 103rd Session of the German Society. Wiesbaden, 7 April 1997].
    Dtsch Med Wochenschr; 1997 Sep; 122(36 Suppl Losartan):1-4. PubMed ID: 9330577
    [No Abstract]   [Full Text] [Related]  

  • 24. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Losartan].
    Pfaffendorf M
    Dtsch Med Wochenschr; 1996 Sep; 121(36):1101-2. PubMed ID: 8846756
    [No Abstract]   [Full Text] [Related]  

  • 26. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of hypertension. A new rapidly effective AT1 blocker].
    MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136675
    [No Abstract]   [Full Text] [Related]  

  • 28. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
    Kjeldsen SE; Omvik P
    Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial.
    Kim JY; Son JW; Park S; Yoo TH; Kim YJ; Ryu DR; Chin HJ
    Trials; 2017 Dec; 18(1):632. PubMed ID: 29284530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report.
    Weber MA
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):247S-251S. PubMed ID: 1290620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL; Porter JA
    Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 35. Losartan: a new antihypertensive drug.
    Dubois M; Wilson TW
    Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of losartan.
    Goldberg A; Sweet C
    Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.